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Molecular Signatures Distinguish Human Central Memory
from Effector Memory CD8 T Cell Subsets1
Tim Willinger,2* Tom Freeman,† Hitoshi Hasegawa,‡ Andrew J. McMichael,* and
Margaret F. C. Callan*§
Memory T cells are heterogeneous in terms of their phenotype and functional properties. We investigated the molecular profiles
of human CD8 naive central memory (TCM), effector memory (TEM), and effector memory RA (TEMRA) T cells using gene
expression microarrays and phospho-protein-specific intracellular flow cytometry. We demonstrate that TCM have a gene ex-
pression and cytokine signaling signature that lies between that of naive and TEM or TEMRA cells, whereas TEM and TEMRA are
closely related. Our data define the molecular basis for the different functional properties of central and effector memory subsets.
We show that TEM and TEMRA cells strongly express genes with known importance in CD8 T cell effector function. In contrast,
TCM are characterized by high basal and cytokine-induced STAT5 phosphorylation, reflecting their capacity for self-renewal.
Altogether, our results distinguish TCM and TEM/TEMRA at the molecular level and are consistent with the concept that TCM
represent memory stem cells. The Journal of Immunology, 2005, 175: 5895–5903.
I mmunological memory is a fundamental feature of the adap-tive immune system. It enables the immune system to re-spond more rapidly and vigorously to infectious pathogens
that have been encountered previously. In particular, memory CD8
T cells play a major role in host defense by rapid recognition and
lysis of virus-infected cells. A memory response differs both quan-
titatively and qualitatively from a primary response (1–3). Thus,
compared with a naive population, the precursor frequency of Ag-
specific memory cells is increased and, furthermore, these cells
have an enhanced capacity to respond to Ag. Despite recent
progress, a clear understanding of the molecular and cellular basis
of T cell memory is still lacking.
Within human CD8 T cells, van Lier and colleagues (4) first
demonstrated the presence of phenotypically and functionally dis-
tinct subsets of primed T cells by analyzing expression of CD27
and CD45RA. Although naive CD8 T cells express both of these
cell surface glycoproteins, cells expressing CD27 but not CD45RA
were reported to have functional properties suggestive of “mem-
ory” cells and those that expressed CD45RA but not CD27 had
functional properties suggestive of “effector” cells (4).
Subsequently, Lanzavecchia and coworkers (5, 6) used expres-
sion of CCR7 and CD45RA to define subsets of CD8 T cells.
According to this scheme, naive T cells (TN)3 (3) express both
CCR7 and CD45RA whereas primed CD8 T cells can be consid-
ered as belonging to one of three different subsets. Two of these
lack expression of CD45RA and thus lie broadly within the van
Lier memory subset. Of these, central memory cells (TCM) express
CCR7 while effector memory (TEM) cells lack expression of
CCR7. In humans, but not in mice, there is a third T cell memory
subset, TEMRA, that includes cells that express CD45RA but lack
expression of CCR7.
TCM and TEM can be distinguished by their different homing and
effector capacities (6). Like naive cells, TCM express CD62 ligand
(CD62L) and CCR7 and home to secondary lymphoid organs. In
contrast, expression of a different set of chemokine receptors (e.g.,
CXCR3) allows TEM and TEMRA to gain access to inflamed pe-
ripheral tissues. Human TEM, and TEMRA in particular, are more
differentiated in terms of effector function than TCM (4, 7–11).
They display potent ex vivo cytotoxicity and produce Th1 cyto-
kines upon stimulation, whereas TCM mainly produce IL-2 and
Th2 cytokines. Further studies have shown that TCM have a higher
proliferative potential and greater resistance to apoptosis, whereas
TEM/TEMRA have a skewed TCR repertoire and are characterized
by a “senescent” replicative history (9, 10, 12–14).
The importance of both TCM and TEM subsets for the control of
infectious diseases and the effectiveness of vaccines has been
shown in several murine studies (15–17). In mice, Ahmed and
colleagues (18) have demonstrated a linear differentiation pathway
TN3 effector3 TEM3 TCM following acute lymphocytic cho-
riomeningitis virus (LCMV) infection. Two other models of CD8
memory T cell differentiation have been proposed: the signal
strength/progressive differentiation model by Lanzavecchia and
coworkers (6) and the “independent” differentiation model by
Pannetier and colleagues (19). However, in humans the develop-
mental relationship among TCM, TEM, and TEMRA is still
controversial.
In this study, we have conducted gene expression and kinase
phospho-protein profiling of CD8 memory subsets to investigate
their molecular programs and their cytokine responsiveness and to
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gain insight into their relationship at the molecular level. We
elected to define memory subsets according to the Lanzavecchia
model in view of the capacity of the model to distinguish between
two apparently functionally distinct subpopulations of CD45RA-
primed T cells (TCM and TEM) and the extensive debate in the
literature concerning the lineage relationship between TCM and
TEM or TEMRA cells. Our results define a molecular basis for the
different functional properties of human CD8 T cell memory sub-
sets and place TCM cells between TN and TEM/TEMRA cells in
terms of their molecular signatures.
Materials and Methods
Isolation of CD8 T cell subsets
PBMC were obtained from buffy coat preparations from four healthy do-
nors by density gradient centrifugation using LymphoPrep (Nycomed) in
accordance with institutional ethics approval. We isolated CD8 T cells by
positive immunomagnetic selection using dynabeads (Dynal) with detach-
ment of the anti-CD8 mAb. Purity of the selected CD3CD8 cells was
98% as assessed by flow cytometry. The CD8 T cells were then stained
with mAbs specific for CCR7 (R&D Systems) and CD45RA (BD Pharm-
ingen) and sorted into TN (CCR7CD45RA), TCM (CCR7CD45RA),
TEM (CCR7CD45RA), and TEMRA (CCR7CD45RA) populations on
a MoFlow Cytometer (DakoCytomation). Purity of isolated subpopulations
was 93–98%. Cell purification procedures were conducted at 4°C to min-
imize in vitro-induced changes in gene expression.
Preparation of cRNA and array processing
Total RNA was extracted from purified CD8 T cell populations using TRI
reagent (Sigma-Aldrich) followed by RNA cleanup with the RNeasy kit
(Qiagen). We confirmed integrity of the total RNA by Lab-on-a-Chip 2100
Bioanalyzer (Agilent) quality control. Double-stranded cDNA was synthe-
sized using a modification of the SMART-PCR protocol described by Peta-
lidis et al. (20). This protocol has been validated regarding the fidelity of
amplification and compares favorably with the direct labeling approach in
terms of sensitivity, speed and cost-effectiveness. Briefly, 300–600 ng of
total RNA was reverse transcribed using a modified SMART CDS Primer
IIA containing a 5 T7 promoter sequence. After double-stranded DNA
synthesis, the cDNA was subjected to 15 rounds of PCR according to the
manufacturer’s recommendations. Biotin-labeled cRNA was generated
from 2 g of double-stranded cDNA by one round of in vitro transcription
with the BioArray High Yield RNA Transcript Labeling kit (Enzo). cRNA
yields were 50 g with A260:A280 ratios of 1.9–2.1. After fragmentation,
labeled RNA was hybridized to Affymetrix HG-U133 plus 2.0 arrays (con-
taining 54,675 probe identifiers (IDs)) according to the manufacturer’s in-
structions. Arrays were scaled to a target intensity of 100 using GCOS
software (Affymetrix). Scaling factors for all arrays were within 2 SDs of
the mean (range, 0.7–1.2). Percentage of genes as scored present on arrays
by GCOS software was 32.8  2.5%. 3 to 5 GAPDH ratios ranged from
0.8 to 1.2. We performed replicate microarray experiments with RNA from
four independent donors. R2 values derived from scatter plots of signal
intensity values were 0.98 or greater for individual replicates of CD8 T cell
populations. All data have been deposited in the European Bioinformatics
Institute ArrayExpress public database. Accession number: E-TABM-40.
Microarray data analysis
We used the comprehensive software package BRB-ArrayTools (21, 22)
for data analysis. First, the robust multiarray average algorithm was applied
for probe-level normalization, background correction, and to calculate log
expression measures (23). Then, to minimize the negative effects of ran-
dom noise, we performed the following filtering steps: First, transcripts
showing minimal variation across the set of arrays (log intensity variation,
p  0.01 with the test hypothesis that gene i has the same variance as the
median variance) were removed. Second, transcripts with mostly unreliable
expression (GCOS present call 4 in 16 samples) were also excluded. This
resulted in 10,854 probe IDs that were used for further unsupervised anal-
ysis to examine the relationship among samples. First, we used standard
average-linkage hierarchical clustering to cluster the samples using the
Pearson correlation as the distance metric. Genes were median centered
before clustering. The so-called R (reproducibility) measure described in
Ref. 24 was used to evaluate the robustness of the clusters. The R measure
is based on perturbing the expression data with Gaussian noise, recluster-
ing, and measuring the similarity of the new clusters to the original clus-
ters. R measure  1 indicates perfect cluster reproducibility. Second, mul-
tidimensional scaling (MDS) analysis was conducted using the Pearson
correlation to measure between sample distances. MDS is related to prin-
cipal components analysis and allows the representation of high-dimen-
sional data in three-dimensional space. The Pearson correlation subtracted
from unity was used to measure the distance between two CD8 T cell
subsets by calculating the average linkage distance (distance range, 0–2)
(25). The average linkage distance represents the mean of all pairwise
distances (linkages) between samples from the two CD8 subsets concerned.
We identified genes that were differentially expressed among the four
CD8 subsets using a random variance F test. The random variance F test
permits sharing information among genes about within-class variation
without assuming that all genes have the same variance (26). It is therefore
well suited to the analysis of microarray data with a relatively small num-
ber of replicates. Genes were considered statistically significant if their p
0.001. We used a multivariate permutation test (21) to provide 95% con-
fidence that the false discovery rate (FDR) was 1% (1000 random per-
mutations). The multivariate permutation test is nonparametric and does
not require the assumption of Gaussian distributions. Using the significance
of microarray analysis algorithm (27) produced similar results. We also
performed a global test of whether the expression profiles differed between
the different CD8 populations by permuting the labels of which arrays
corresponded to which population. For each permutation, the p values were
recomputed and the number of genes significant at the 0.001 level was
noted. The proportion of the permutations that gave at least as many sig-
nificant genes as with the actual data was the significance level of the
global test.
Gene ontology (GO) overrepresentation analysis
Onto-Express was used to translate gene lists into functional profiles and to
identify overrepresented GO annotation categories (28). Multiples (probes
corresponding to the same gene) were removed before analysis. Enrich-
ment of GO categories and associated p values were calculated based on
hypergeometric distribution statistics. We obtained similar results when
applying a 2 test. Multiple testing correction was conducted with the Bon-
ferroni step-down (Holm) procedure (  0.05). The Holm procedure is
based on the family-wise error rate and a conservative global measure of
type I error.
Analysis of cytokine signaling by phospho-specific intracellular
FACS
PBMC were stimulated in serum-free RPMI 1640 (Invitrogen Life Tech-
nologies) for 15 min at 37°C in 5% CO2,with or without cytokines, at the
following concentrations: IL-2 (200 U/ml), IL-4, IL-6, IL-7, IL-10, IL-12,
IL-15, IL-18, TNF-, IFN-, and IFN- (all 50 ng/ml). All cytokines were
purchased from R&D Systems apart from IL-2 (Biotest), IL-7/TNF- (Pep-
roTech), and IL-18 (Leinco Technology). We conducted simultaneous
staining of PBMC for surface markers and for intracellular phosphorylated
STAT and NF-B proteins according to the protocol developed by Nolan
and colleagues (29). Briefly, PBMC were fixed in 1.5% formaldehyde for
10 min at room temperature and permeabilized in methanol for 15 min on
ice. This was followed by a rehydration step before staining the cells for 1 h
at room temperature. We used CD62L-FITC/-PE, CD45RA-allophycocya-
nin, and CD8-PerCP Abs for surface staining and phospho-specific Abs
STAT1 (Y701)-PE, STAT3 (Y705)-PE, STAT4 (Y693)-Alexa Fluor 488,
STAT5 (Y694)-PE, STAT6 (Y641)-Alexa Fluor 488 (all BD Biosciences),
NF-B-p65 (S536)-Alexa Fluor 488 (Cell Signaling Technology) for in-
tracellular staining. Isotype-matched irrelevant Abs were used as controls.
Specificity of intracellular phospho-staining was verified by using blocking
phospho-peptides (1 g/sample; Santa Cruz Biotechnology). Geometric
mean fluorescence intensities (GMFI) of phospho-STAT/-NF-B proteins
were calculated for both unstimulated and stimulated CD8 T cell subsets.
We determined differences in phosphorylation by obtaining the log2 ratios
of GMFI of stimulated vs unstimulated cell populations. Differences in
basal phosphorylation were compared by calculating each sample’s GMFI
log2 ratio divided by the minimum among all samples. We then performed
phosphorylated kinase clustering analysis using Cluster and Treeview pro-
grams (Michael Eisen, University of California, Berkeley, CA). One-way
ANOVA was used to determine the significance of differences in phos-
phorylation between CD8 T cell subsets. Post hoc testing was conducted
using Tukey’s significant difference test (  0.05).
Results
Relationships between CD8 memory T cell expression signatures
We isolated highly purified CD8 TN (CCR7CD45RA), TCM
(CCR7CD45RA), TEM (CCR7CD45RA), and TEMRA
(CCR7CD45RA) populations from four healthy donors for
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gene expression profiling using Affymetrix oligonucleotide mi-
croarrays. Unsupervised data analysis methods were used to ex-
plore the relationship between CD8 T cell subsets. First, we sub-
jected the 16 samples (four replicates per subset) to hierarchical
clustering using a filtered set of 10,854 probe IDs. We found that
for both TN and TCM all four replicates clustered together (Fig.
1A). In contrast, TEM and TEMRA samples from the same donors
formed individual clusters. Thus, two main clusters could be dis-
tinguished: TN/TCM and TEM/TEMRA. We confirmed the robust-
ness of these two main clusters by obtaining a high overall cluster
reproducibility measure (R index 0.949, dendrogram cut at level
of four clusters). Second, we performed MDS analysis to assess
the distances between the expression signatures of the CD8 T cell
subsets. MDS could separate TEM and TEMRA, but these two pop-
ulations were still in close proximity (Fig. 1B). In contrast, their
transcriptional profiles placed TCM replicates between TN and
TEM/TEMRA. We also calculated average linkage distances be-
tween TN and the different memory subsets as a measure for their
relatedness. This showed that the gene expression profile of TCM
was closer to TN than were the profiles of TEM or TEMRA (Fig. 1C).
Furthermore, we determined the number of differentially expressed
genes between the CD8 T cell subsets by individual pairwise com-
parisons: It was highest for TN vs TEMRA and TCM vs TEMRA and
lowest for TEM vs TEMRA (data not shown), again confirming the
dichotomy TN/TCM vs TEM/TEMRA. Finally, we conducted a global
permutation test to assess whether gene expression profiles be-
tween the CD8 subsets differed. The significance values (TEM vs
TEMRA p  0.05714; all other pairwise comparisons p  0.02857)
again suggest that TEM and TEMRA have the most similar gene
expression profiles among all CD8 T cell subsets. In summary,
analysis of our results, using several different approaches, indicate
that the TEM and TEMRA subsets are closely related, whereas TCM
have an expression signature that is distinct from that of the other
primed T cells and is more closely related to the TN population.
Genes differentially expressed between CD8 T cell memory
subsets
Next, we identified genes that showed significant differential ex-
pression among the four CD8 T cell subsets. We used stringent
statistical criteria, including a permutation test to minimize the
FDR (see Materials and Methods). A total of 2092 probe IDs
corresponding to 940 named genes met our criteria for differential
expression: p  0.001, FDR 1% with 95% confidence.4 Hierar-
chical clustering of the differentially expressed genes revealed six
main clusters (Fig. 2). Number of probe IDs in each cluster was as
follows: 103 (cluster 1), 1369 (cluster 2), 92 (cluster 3), 16 (cluster
4), 129 (cluster 5), and 383 (cluster 6). Two major patterns could
be identified among the clusters: First, genes with low expression
in TN with increasing expression from TCM3 TEM3 TEMRA
(clusters 2 and 3), termed “effector memory signature.”4 Second,
genes with high expression in naive cells with decreasing expres-
sion from TCM3 TEM3 TEMRA (clusters 5 and 6), termed “naive
signature.”4 Cluster 1 consisted of genes with higher expression in
TCM and TEM.4 Cluster 4 comprised genes with a “TCM-specific”
expression pattern. Surprisingly, very few genes fell within this
category and probe IDs for CD28 accounted for 3 of the 16 in-
cluded in this cluster (Fig. 2). Overall, 70% of all differentially
expressed genes had expression levels in TCM that were interme-
diate between their expression levels in the TN population and the
TEM and TEMRA subsets. These analyses again suggest that, at the
4 The online version of this article contains supplemental material.
FIGURE 1. Relationships between CD8 memory T cell expression sig-
natures. A, Hierarchical clustering of CD8 T cell subset replicates. Average
linkage clustering using the Pearson correlation distance was performed
based on a set of 10,854 probe IDs (filtered for random noise) from Af-
fymetrix HG-U133 Plus 2.0 gene chip experiments. Overall cluster repro-
ducibility was assessed using the R index (see Materials and Methods). The
red line indicates the level at which the dendrogram was cut to calculate the
R index. B, MDS analysis of CD8 T cell subset replicates. The three-
dimensional plot shows between-sample distances calculated with the
Pearson correlation metric using the same gene set as in A. Each dot rep-
resents a single replicate sample. Color coding: TN (red), TCM (green), TEM
(dark blue), and TEMRA (light blue). C, Average linkage distances between
CD8 TN and memory subsets. Average linkage distances between each
CD8 memory T cell subset and TN were calculated as described in Mate-
rials and Methods based on the same gene set as in A and B. Error bars
represent SEs (SD of pairwise linkages divided by the square root of the
number of linkages).
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level of gene expression, TCM represent a differentiation state that
is intermediate between TN cells and the TEM and TEMRA subsets.
The effector memory signature of human CD8 T cells
Genes in clusters 2 and 3 (effector memory signature) appear to
represent genes that underpin the known high effector capacity of
TEM and TEMRA. We identified GO categories that displayed sta-
tistical overrepresentation among cluster 2 and 3 genes (hypergeo-
metric statistics, Holm multiple testing correction,   0.05): GO
Biological Processes such as “immune response,” “cellular defense
response,” “cytolysis,” and “protein transport” were overrepre-
sented among the effector memory signature genes (Table I). Thus,
TEM and TEMRA highly expressed genes encoding lytic granule
proteins like granzyme A (GZMA), granzyme B (GZMB), granzyme
H (GZMH), and perforin (PRF1) as well as TNFSF10 (TRAIL) and
TNFSF6 (FASL) that mediate perforin-independent apoptosis of
target cells.4 Also TEM and TEMRA showed strong expression of
genes involved in protein sorting to granules and granule transport/
exocytosis such as HPS3, MYO5A, RAB27A, and RABGGTA. Hu-
mans with genetic defects of any of these genes have impaired T
cell cytotoxicity (30). Finally, genes encoding inflammatory cyto-
kines (e.g., IFNG (IFN)) and chemokines (e.g., CCL5 (RANTES))
were also present in clusters 2 and 3. Consistent with this, in TEM
and TEMRA subsets, we found higher expression of transcription
factors that control effector function in CD8 T cells (31), i.e.,
EOMES, TBX21 (T-BET), REL, NFATC2, and NFATC3.4
In the case of some proteins, particularly those expressed at the
cell surface, Abs capable of detecting expression are available.
Using these we have confirmed higher expression of CCR7,
CD62L, CD27, and CD28 in TN and TCM subsets at the protein
level (data not shown). Apart from effector molecules, differential
expression of other genes from clusters 2 and 34 between different
CD8 T cell subsets has previously been described at the protein
level: ITGAL (CD11a), ITGB2 (CD18), ITGAM (CD11b), ITGA4
(CD49d), KLRB1 (CD161), KLRD1 (CD94), killer Ig-like receptor
family members, and TNFRSF6 (CD95). Therefore, the results of
the protein expression studies are consistent with the results of our
gene expression study. Overall, this further strengthens the validity
of our gene expression data.
Cytokine signaling signatures of CD8 T cell memory subsets
We observed differential expression of cytokine receptor mRNA in
our microarray analysis (Table II). For example, naive CD8 T cells
were characterized by higher expression of receptors for IL-6 (IL-
6ST) and IL-7 (IL-7R). In contrast, TEM and TEMRA showed pref-
erential expression of receptors for IL-2 family cytokines (IL-2RB,
FIGURE 2. Two-way hierarchical clustering of CD8 subset samples and differentially expressed genes. A set of 2092 probe IDs (corresponding to 940
genes) was identified as differentially expressed between CD8 T cell subsets (p  0.001, FDR 1% with 95% confidence) and used for clustering. Each
row in the heat map represents a gene and each column a CD8 subset sample. As shown in the color bar, red indicates higher than median expression
(up-regulation) and green indicates lower than median expression (down-regulation). The six main gene clusters are indicated on the right. Higher
magnification of cluster 4 is displayed on the right. Gene symbols are shown next to the heat map.
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IL-2RG) and for inflammatory Th1-type cytokines (TNFR2, IL-
12RB1, IL-18R1, IL-18RAP, IFNGR1). This prompted us to inves-
tigate cytokine signaling in CD8 T cell subsets at the single-cell
level using multiparameter flow cytometry (32, 33). In doing so,
we aimed to generate a functional data set that could be subject to
clustering and scaling analysis and give further insight into the
relationship between the TCM and TEM/TEMRA subsets.
Activated STAT and NF-B proteins that transduce cytokine
signals were detected with phospho-specific Abs by intracellular
FACS staining. Methanol permeabilization can compromise de-
tection of some surface Ags (29), and we observed loss of dis-
crimination for CCR7 surface staining (data not shown). There-
fore, we substituted CCR7 with CD62L as a surface marker to
identify CD8 T cell subsets in conjunction with CD45RA. CCR7
and CD62L expression largely overlap in CD8 T cells (Ref. 10,
and own data not shown). In all, for each of the four T cell subsets,
we analyzed basal expression levels of intracellular phosphory-
lated STAT1, STAT3, STAT4, STAT5, STAT6, and NF-B. We
also analyzed expression levels of phosphorylated STAT1 in cells
stimulated with IFN- or IFN-, phosphorylated STAT3 in cells
stimulated with IL-6 or IL-10, phosphorylated STAT4 in
cells stimulated with IL-12 or IFN-, phosphorylated STAT5 in
cells stimulated with IL-2, IL-7, or IL-15, phosphorylated STAT6
in cells stimulated with IL-4, and phosphorylated NF-B in cells
stimulated with IL-18 or TNF-. Examples of phospho-specific
intracellular staining are shown in Fig. 3. Interestingly, ex vivo
CD8 T cells had elevated levels of P-STAT1 and P-STAT5, which
could be increased further by cytokine stimulation (Fig. 3A). We
confirmed specificity of intracellular phospho-staining by using
blocking phospho-peptides (data shown). In addition, we found
Table II. Expression of cytokine receptor mRNA in CD8 T cell subsetsa
Gene Symbol p TN TCM TEM TEMRA
IL6ST 0.000000 596.9 235.2 164.9 171.3
1.0 0.4 0.3 0.3
TGFBR1 0.000000 349 197.5 465.1 853.6
1.0 0.6 1.3 2.4
TGFBR3 0.0000003 302.1 1065.7 1541.1 2021.2
1.0 3.5 5.1 6.7
IL10RA 0.0000016 571.6 1034.8 1393.5 1299.4
1.0 1.8 2.4 2.3
TGFBR2 0.0000022 233.6 141.5 123.5 126.8
1.0 0.6 0.5 0.5
IL2RB 0.0000024 933.5 2021.4 2767.1 2859
1.0 2.2 3.0 3.1
TNFRSF1B 0.0000034 181.6 480.3 763.9 775.6
1.0 2.6 4.2 4.3
IL18RAP 0.0000074 136.3 366.3 966.5 902.4
1.0 2.7 7.1 6.6
ACVR1C 0.0000168 201.5 124.9 97.1 84.5
1.0 0.6 0.5 0.4
CRLF3 0.0000191 1655.5 851 1077.4 1299.3
1.0 0.5 0.7 0.8
IL18R1 0.0000288 39.1 73.9 108.4 110.7
1.0 1.9 2.8 2.8
IL12RB1 0.0001641 496.3 577.6 900.6 982.4
1.0 1.2 1.8 2.0
IL27RA 0.0001734 220.8 115 151.3 215.5
1.0 0.5 0.7 1.0
IL2RG 0.0002810 1743.4 1458.7 1978.9 2416
1.0 0.8 1.1 1.4
IFNGR1 0.0003961 689.7 1031.9 1461.6 1241.3
1.0 1.5 2.1 1.8
ACVR2 0.0004012 431 646.3 345.8 343.8
1.0 1.5 0.8 0.8
IL7R NS 3699.1 2732.9 2189.8 1348.6
1.0 0.7 0.6 0.4
IL4R NS 734.8 858.5 709.9 539.7
1.0 1.2 1.0 0.7
a This table lists differentially expressed genes encoding cytokine receptors. Gene expression values (RMA expression measures), fold change values relative to TN (in bold),
and associated p are shown.
Table I. GO categories overrepresented in effector memory signature
(clusters 2 and 3)a
GO Biological Process
No. of
Genes p
Immune response 47 0
Cellular defense response 15 0.000000002
Intracellular signaling cascade 35 0.000000304
Signal transduction 66 0.000000563
Cell growth and/or maintenance 29 0.000028800
Cell motility 13 0.000432000
Response to stress 10 0.001663760
Cytolysis 3 0.002187597
Nucleobase, nucleoside, nucleotide,
and nucleic acid metabolism
6 0.010724858
Cell surface recepton-linked signal
transduction
12 0.011990255
Protein transport 15 0.012280396
Cell matrix adhesion 8 0.015343897
Lipid transport 6 0.015350114
Response to oxidative stress 5 0.020518426
Cell proliferation 16 0.034058535
DNA metabolism 3 0.040130732
a The association of genes from clusters 2 and 3 (Fig. 2) with biological processes
was analysed using Onto-Express. Biological processes (GO tree levels 4 and 5) with
a total number of three or more genes and p  0.05 are displayed.
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that, as known from the literature, some cytokines did not induce
phosphorylation of certain STAT proteins, e.g., STAT1 and
STAT3 in response to IL-4 or STAT5 and STAT6 in response to
IL-10 (data not shown). Importantly, in TN and TCM, we observed
high STAT3 phosphorylation in response to IL-6 and in TN, TCM,
and TEM, we observed high STAT5 phosphorylation in response to
IL-7 (Fig. 3B). In contrast, TNF- induced higher NF-B phos-
phorylation in TEM/TEMRA. These results are in line with the dif-
ferential mRNA expression of receptors for IL-6, IL-7, and TNF-
derived from the microarray data.
In all we performed experiments on samples of blood taken
from 10 different donors and found differences in levels of basal
STAT/NF-B phosphorylation between the four different T cells
subsets. Interestingly, TCM were characterized by significantly
higher cumulative basal STAT/NF-B phosphorylation compared
with TEM and TEMRA subsets (TCM vs TEM, p  0.006, TCM vs
TEMRA, p  0.001, one-way ANOVA/Tukey’s post hoc test). We
also found higher basal P-STAT1 ( p  0.037) and P-STAT5 lev-
els ( p  0.013) in TCM compared with TEMRA.
Furthermore, the four different T cell subsets responded differ-
ently, in terms of changes in STAT/NF-B phosphorylation, to
stimulation with cytokines (Fig. 4). Despite their already elevated
P-STAT5 levels, overall TCM had higher induction of STAT5
phosphorylation in response to IL-2 family cytokines (IL-2: TCM
vs TN, p  0.001, TCM vs TEM, p  0.044, TCM vs TEMRA, p 
0.001; IL-7: TCM vs TEMRA, p  0.001, IL-15: TCM vs TN, p 
0.002, TCM vs TEMRA, p 0.011). In TN we detected strong phos-
phorylation of STAT1 in response to IFN, STAT3 in response to
IL-6, STAT5 in response to IL-7, and STAT6 in response to IL-4.
Overall, TN and TCM displayed the highest cumulative cytokine-
stimulated phospho-response (TN vs TEMRA, p  0.01, TCM vs
TEMRA, p  0.02). Finally, we found preferential phosphorylation
of NF-B in response to IL-18 and TNF- in the TEM and TEMRA
subsets (IL-18: TEM vs TN, p  0.001, TEM vs TCM, p  0.001,
TEM vs TEMRA, p  0.008; TNF-: TEM vs TN, TEM vs TCM,
TEMRA vs TN, and TEMRA vs TCM, all p  0.001). Thus, human
CD8 T cell subsets are characterized by the differential activation
of cytokine signaling pathways.
We clustered CD8 T cell subsets based on their cytokine sig-
naling profiles. The 18-parameter phospho-signature, based on the
6 basal and 12 stimulated levels of phosphorylated STAT and
NF-B molecules, again placed TCM between TN and the TEM and
TEMRA subsets (Fig. 5A). Interestingly, the responses to the proin-
flammatory cytokines IL-12, IL-18, and TNF- clustered together
and formed a bigger cluster with IL-10 and IL-15. In contrast,
IFNs were found in a cluster with IL-4, IL-6, and IL-7. We also
performed MDS analysis based on our FACS phospho-proteome
data. Similar to the gene expression data, TCM took up an inter-
mediate place between TN and TEM/TEMRA (Fig. 5B). Consistent
with this, the average linkage distance between TCM and TN was
smaller than that between TEM or TEMRA and TN (Fig. 5C). Thus,
the cytokine signaling signatures support the observations from
transcriptional profiling in terms of the molecular relationship of
CD8 memory cells.
Discussion
In this study, we identified both the gene expression and cytokine
signaling profiles of CD8 TN, TCM, TEM, and TEMRA cells. Our
results provide a molecular basis for the different functional prop-
erties of different memory subsets, especially in terms of their
self-renewal and effector capacity. They also shed light on the
relationship between the primed T cell subsets.
In contrast with a recent study (34) that used the van Lier clas-
sification of CD8 T cells, we used the Lanzavecchia model as a
basis for our experiments. This allowed us to compare the prop-
erties of the TCM subset with those of other T cell populations.
Interestingly, we found a clear dichotomy between TCM and the
two effector memory (TEM and TEMRA) CD8 T cell subsets at the
molecular level. Analysis of both gene expression and cytokine
signaling showed that TCM cells were significantly more closely
related to TN cells than TEM or TEMRA cells were. Furthermore, the
results of the gene expression analysis imply that TCM cells form
a population that is broadly intermediate between TN and TEM or
TEMRA cells. The observation that there are very few truly “TCM-
specific” genes is most consistent with the idea that these cells
form part of a continuum of differentiation or functional states
(35–37). However, it is possible that some of the defining features
of TCM are epigenetically imprinted, but not yet actively tran-
scribed, and are therefore not identified by transcriptional
profiling.
In many respects, the genetic profile of CD8 TCM cells suggests
they are equipped with features of both naive and effector memory
cells. Thus, TCM possess some stem cell-like qualities, such as a
high proliferative capacity, that are also found in the TN cell pop-
ulation. In this regard, TCM displayed high basal and IL-2 family-
induced STAT5 phosphorylation. Cytokines of the IL-2 family,
which mainly signal through STAT5, are known to play an im-
portant role in the differentiation and homeostasis of CD8 T cells
(38, 39). Thus, IL-15 can induce the homeostatic proliferation of
CD8 memory T cells, whereas IL-7 has recently been implicated in
the survival of murine CD8 memory precursors, which can be
FIGURE 3. Analysis of cytokine signaling in CD8 T cell subsets by
phospho-specific intracellular FACS. A, Phospho-STAT proteins were de-
tected in unstimulated or cytokine-stimulated PBMC after staining with
Abs for CD8 and P-STAT. A representative example from one donor is
shown for STAT1, STAT3, and STAT5 phosphorylation in response to
IFN-, IL-10, and IL-15, respectively (thick line histograms). Thin line
histograms indicate basal phosphorylation and dashed line histograms in-
dicate isotype control staining. Histograms are gated on CD8 lympho-
cytes. B, Phospho-STAT/NF-B proteins were detected in unstimulated or
cytokine-stimulated PBMC after staining with Abs for CD8, CD62L,
CD45RA, and P-STAT/P-NF-B. Gating of CD8 cells based on CD62L/
CD45RA expression was used to define TN, TCM, TEM, and TEMRA subsets.
A representative example from one donor is shown for STAT3, STAT5,
and NF-B phosphorylation in response to IL-6, IL-7, and TNF-, respec-
tively (thick line histograms). Thin line histograms indicate basal
phosphorylation.
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identified by selective expression of the IL-7R (40). Furthermore,
a recent study found that STAT5 regulates the self-renewal and
differentiation of human memory B cells (41). Therefore our re-
sults might explain why TCM have a greater expansion potential
and self-renewal capacity than effector memory cells, TEMRA in
particular. In contrast, we found that both effector memory subsets
strongly express genes involved in CD8 T cell effector function.
However, our data also show that the gene expression profile of
TCM is biased to some extent toward effector differentiation, char-
acteristic of effector memory cells. Thus, mRNAs encoding effec-
tor molecules like perforin, granzyme A, IFN-, and RANTES
were up-regulated in TCM compared with TN.
The lineage relationship between CD8 T cell subsets remains
controversial. Our study is cross-sectional in design and therefore
does not directly address questions relating to T cell lineage. It is
however interesting to consider the results of our study in the light
of recently proposed models. Lanzavecchia and colleagues (6)
have suggested a signal strength model of T cell memory differ-
entiation. According to this model, TCR signal strength determines
the memory cell fate a naive T cells acquires: A low Ag dose leads
to the differentiation TN3 noneffector3 TCM, whereas a high Ag
dose to TN3 effector3 TEM differentiation. Their work also sug-
gests that human TCM further differentiate into TEM following Ag
stimulation and into TEMRA in response to homeostatic cytokines
(9). The results of our microarray analysis showing that the gene
expression profile of TCM cells is largely intermediate between TN
and TEM or TEMRA subsets would be consistent with this type of
model. In contrast, another model based on the idea that TCM and
TEM are independent populations has been proposed by Pannetier
and coworkers (19), who found that the TCR repertoires of influ-
enza-specific TCM and TEM are largely distinct. We did not find
many truly TCM- and TEM-specific genes and this argues against an
independent TCM/TEM differentiation pathway. Finally, Ahmed
and coworkers (18) have defined a linear differentiation pathway
TN3 effector3TEM3 TCM in a murine model of acute LCMV
infection. Interestingly, this TEM3 TCM conversion does not oc-
cur in chronic LCMV infection (42). A second study by Pannetier
and colleagues (43) using murine H-Y-specific CD8 T cells con-
firmed this linear differentiation pathway although there was also
evidence for an independent TCM/TEM differentiation pathway.
The observation that TCM cells are intermediate between TN and
TEM cells does not obviously support this type of linear differen-
tiation model. However, the present study is cross-sectional in na-
ture and therefore we do not exclude the possibility that TEM con-
vert to TCM. Interesting questions about the plasticity of the
genetic program of the CD8 memory T cell remain and further
work will be needed to address these issues. Finally, it is notewor-
thy that the studies by Ahmed and Pannetier have not examined the
TEMRA subset in relation to TCM and TEM as we did in the present
work. Effector memory cells re-expressing CD45RA form a size-
able population in human peripheral blood and are likely to have
an important role in human CD8 T cell memory.
FIGURE 4. Differential activation of cy-
tokine signaling pathways in CD8 T cell sub-
sets. Target phosphorylations in CD8 T cell
subsets to the indicated cytokines were ana-
lyzed by phospho-specific intracellular
FACS. Log2 ratios of fluorescent intensities
(geometric mean) of stimulated cells relative
to unstimulated cells are shown (n  10).
Mean phospho-responses for each cytokine-
stimulated state are indicated by black bars.
Values of p (determined by one-way
ANOVA testing,   0.05) are shown for
each phospho-signaling node.
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In conclusion, our genomic and phospho-proteomic study dem-
onstrates a dichotomy between CD8 TCM and TEM/TEMRA cells at
the molecular level and suggests that human TCM cells represent
an intermediate state between the TN and the TEM/TEMRA popu-
lations in terms of CD8 memory differentiation and function. By
defining molecular signatures for CD8 memory subsets, we pro-
vide a framework for the further molecular characterization of hu-
man CD8 T cell memory.
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